- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07208318
Improving Vision in Aging Adults Through Non-Invasive Brain Stimulation
As we grow older, many of us notice changes in our vision that can affect daily activities like reading, driving, or recognizing faces. This important clinical trial explores an innovative approach to address age-related visual decline using safe, non-invasive brain stimulation technology. The research focuses on understanding how brain wave patterns change with aging and whether we can restore more youthful visual processing through targeted interventions.
The study investigates specific brain rhythms called alpha and gamma waves that work together to help us process visual information. Think of these brain waves like musicians in an orchestra – when they're perfectly synchronized, they create beautiful music (clear vision), but when they fall out of sync, the performance suffers (blurry or impaired vision). As we age, this synchronization between alpha and gamma waves appears to deteriorate, leading to the visual difficulties many older adults experience.
This groundbreaking research uses high-definition transcranial electrical current stimulation (HD-tACS) – a completely non-invasive, painless technology that applies very mild electrical currents to the scalp. Unlike medications or surgeries, this approach works by gently guiding the brain's natural rhythms back toward their optimal patterns. Each participant receives personalized stimulation based on their unique brain anatomy and natural rhythm frequencies, making this a truly customized approach to visual rehabilitation.
The study will include 240 adult participants across different age groups, with a particular focus on older adults experiencing normal age-related visual changes. Participants will attend five study sessions where they'll receive either active stimulation or a sham (placebo) treatment in a double-blind design – meaning neither participants nor researchers know which treatment is being administered during each session. This rigorous design ensures the results are scientifically valid and not influenced by expectations or biases.
Researchers will measure several aspects of visual function, including contrast sensitivity (the ability to distinguish objects from their background) and 3D shape perception from motion cues. These measurements directly relate to real-world visual challenges like reading text with poor contrast, navigating in dim lighting, or judging distances while driving. The study will track whether brain stimulation can improve these visual abilities immediately following treatment sessions.
What makes this research particularly innovative is its bidirectionality – researchers can test whether placing gamma waves at different points in the alpha wave cycle either improves or temporarily disrupts vision. This helps establish a clear cause-and-effect relationship between brain wave patterns and visual perception. The study also examines whether individuals with greater age-related visual decline show more significant improvement from the intervention, which could help identify who might benefit most from this approach in the future.
The importance of this research extends far beyond the laboratory. Age-related visual decline affects millions of older adults worldwide, impacting quality of life, independence, and safety. Current solutions like stronger glasses or brighter lighting only partially address these challenges. If successful, this non-invasive brain stimulation approach could offer a new way to maintain visual function as we age without medications or invasive procedures. The technology could potentially be adapted for home use, making visual maintenance as routine as physical exercise for brain health.
This research also contributes to our broader understanding of brain aging and how we might intervene in age-related cognitive decline more generally. The methods developed here could eventually be applied to other sensory systems or cognitive functions affected by aging. Furthermore, by establishing clear links between specific brain rhythm patterns and perceptual abilities, this work helps build foundation for future treatments for various neurological conditions affecting vision and perception.
For patients and caregivers, this research represents hope for maintaining visual independence throughout the aging process. The non-invasive nature of the intervention makes it particularly appealing for older adults who may be unable to tolerate more aggressive treatments. The personalized approach recognizes that each person's brain ages differently, suggesting that future visual rehabilitation might be tailored to individual needs and patterns of age-related change.
The study's comprehensive exclusion criteria ensure participant safety while maintaining scientific rigor. By carefully screening for conditions that might affect results or participant wellbeing, the researchers can confidently attribute any improvements to the intervention itself rather than other factors. The inclusion of both younger and older adults allows for direct comparisons that will help clarify what changes represent normal aging versus potential pathology.
As our population continues to age, research like this becomes increasingly vital for maintaining quality of life and reducing healthcare burdens. Visual impairment in older adults contributes to falls, social isolation, depression, and loss of independence. Interventions that can slow or reverse age-related visual decline could have profound impacts on public health and individual wellbeing. This study represents an important step toward developing safe, effective, and accessible solutions for one of the most common challenges of aging.
Upcoming Clinical Trials
-
NCT07634523RecruitingSarcopenia | Total Knee Arthroplasty
-
NCT07634536Not yet recruitingAcute Myeloid Leukemia | Myelodysplastic Syndromes | Myeloproliferative Neoplasm
-
NCT07634549Recruiting
-
NCT07634562Not yet recruiting
-
NCT07634588Not yet recruitingNeck Pain | Myofascial Pain Syndrome | Work-Related Musculoskeletal Disorders
-
NCT07634601Not yet recruitingRecurrent Endometrial Carcinoma | Advanced Endometrial Carcinoma | Metastatic Endometrial Carcinoma | Stage III Endometrial Cancer | Stage IV Endometrial Cancer
-
NCT07634627RecruitingAdolescent Idiopathic Scoliosis (AIS) | Neuromuscular Scoliosis
-
NCT07634640RecruitingHeart Failure With Preserved Ejection Fraction (HFPEF)
-
NCT07634653Not yet recruitingLeukemia | Acute Lymphoblastic Leukemia | Lymphoblastic Lymphoma | Acute Leukemia | Acute Lymphoid Leukemia
-
NCT07634666Not yet recruitingUrologic Cancer | Myocardial Injury After Non-cardiac Surgery | Major Adverse Cardiovascular Events (MACE)
-
NCT07634679Not yet recruitingCesarean Scar Defect (Isthmocele)
-
NCT07634692Not yet recruiting